Did you know that the neuroprotective properties of CBD promote Alzheimer’s disease treatments?
👉 Science is increasingly identifying links between the neuroprotective properties of cannabinoids and neurodegenerative diseases, including dementia and Alzheimer’s disease. About 55 million people worldwide are estimated to suffer from dementia and this number is increasing every day, along with the aging of the population.
Alzheimer’s disease, which causes cognitive and functional decline, is a type of dementia that is the most common neurodegenerative disease worldwide and accounts for the majority of these millions of cases. Currently, there is no cure for Alzheimer’s disease, and existing treatments focus only on relieving symptoms, not slowing down the progression of the disease.
Can medical cannabis offer new hope?
👉 Several studies have shown that medical cannabis can be used to alleviate common symptoms of Alzheimer’s – such as aggression, agitation and anxiety. The neuroprotective properties of the cannabinoids CBD, THC and CBN prevent cell death and brain damage, which is a reason to consider the use of medical cannabis as a new treatment for dementia.
Which product to choose? 👉 Get in touch with us and we can choose the right product for you together. #pellcare
